Drugs / CBD
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05182697 Comparator | Feb 2024 → May 2026 overdue | autism spectrum disorder | Neurothera Labs Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05182697 ↗ |
| Route | Oral | “Oral CBD oil plus pills of CannAmide (palmitoylethanolamide (PEA) 400 mg twice daily” NCT05182697 ↗ |